Pfizer (PFE) reported third-quarter revenue of $16.6 billion, above the $15.9 billion analyst expectation, and adjusted EPS of $0.87 versus $0.73 estimates. It raised full-year adjusted EPS guidance to $2.95 to $3.05 from a prior $2.80 to $3, and expects savings of about $9.7 billion through 2029. Revenue from launched and acquired products rose 32% in the quarter, while the company generates less revenue from COVID products than in the past. The article argues the stock is undervalued, with a forward P/E of about 10 and a dividend yield of 5.6%, even though it is up more than 20% this year and still down more than 30% over five years.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
Pfizerpharmaceuticalsearningsdividends
Open a keyword to see other news on the same topic.
Related news
- Pfizer Stock Is Finally Showing Signs of Life. Could This Be the Start of a Much Bigger Rally?
Pfizer shares, long overlooked despite solid fundamentals and an attractive valuation, have climbed 18% so far this year, their best performance since 2021, though they remain about 30% lower over five years. The article suggests investors may be rotating from tech into healthcare, citing recent moves in two exchange-traded funds. Pfizer's yield of 5.8% is more than five times the S&P 500 average of 1%. Its trailing P/E of 37 looks high because restructuring and impairment charges weigh on earnings, but its forward P/E of about 10 suggests the stock is still undervalued. The author believes the market will eventually recognise this, although long-term growth questions remain.
- Pfizer Just Declared Its 352nd Straight Quarterly Dividend. Is the 6% Yield Safe?
Pfizer declared a $0.43 fourth-quarter dividend, its 352nd consecutive quarterly payout, which annualizes to $1.72 per share and a 5.9% yield, well above the roughly 1% average S&P 500 yield. The article asks whether the payout is sustainable, noting Pfizer halved its dividend in 2009 but has raised it every year since 2010. Eliquis and Xeljanz lose U.S. patent exclusivity this year, and Ibrance and Xtandi follow next year, which pressures revenue. Nurtec grew 18% in the second quarter, Lorbrena 37% and Padcev 23%, and free cash flow of about $11 billion over four quarters exceeded dividend payments by more than $1 billion. The author concludes that the dividend's durability depends on whether new pipeline drugs can replace the expiring ones.
- 2 High-Yield Dividend Stocks Worth Buying Before 2026 Ends
Verizon (VZ) and Pfizer (PFE) are presented as two high-yield dividend stocks worth considering before 2026 ends. Verizon added more than 1 million mobility and broadband connections in the first half, and management raised full-year guidance for the second straight quarter; its quarterly dividend of about $0.71 per share, declared in September 2026, implies a forward yield near 6.5%. Pfizer declared a fourth-quarter dividend of $0.43 per share in October 2026, a forward yield of about 6.1%, marking its 352nd consecutive quarterly payout. The company is building growth through oncology and specialty medicines, with 96 programs in clinical development, including 31 in phase 3. The article suggests Verizon suits investors seeking steadier income, while Pfizer may appeal to those wanting income plus growth.
- Better High-Yield Dividend Stock: Pfizer vs. UPS
Pfizer yields 6.3% and UPS yields 7.0%, and both raised their 2026 revenue guidance this summer. In the twelve months to June 2026, dividends took 89% of Pfizer's free cash flow and 99% of UPS's, leaving little cushion for either. Pfizer's Q2 2026 revenue rose 3% (1% operationally) as newer products grew 18%, while COVID-19 sales shrink and patent losses weigh on revenue through 2028; its CEO says dividend growth returns after that period. UPS's Q2 2026 revenue rose 7.6% to $22.8 billion after it finished cutting Amazon volume, though its dividend per share rose only 0.6% in fiscal 2025. The article concludes UPS is the better high-yield pick because of faster growth and lower leverage (1.63x vs 1.97x net debt/EBITDA), while noting Pfizer's dividend is better covered.
- Forget Treasury Bonds: This 6%-Yielding Pharma Stock Pays You to Wait for Its Pipeline
Pfizer (PFE) is expanding beyond its COVID-19 vaccine, with revenue from launched and acquired products up 18% year over year in the second quarter and the midpoint of its full-year guidance raised. The company is building its oncology business through a collaboration with Innovent Biologics covering 12 early-stage cancer programs. Pfizer declared a quarterly dividend of $0.43, its 351st consecutive payout, equal to a forward yield of just over 6%. The article argues this dividend pays investors while the pipeline develops, though unlike Treasury bonds, Pfizer's share price and dividend depend on business performance.
- Pfizer Inc. Q3 2026 Earnings Call Summary
Related markets
Latest news
- [UPDATE] CNN projects Democrats will take the House from Republicans, President Trump denies responsibility
Democrat Chris Pappas won the New Hampshire Senate seat, defeating Republican John Sununu. AP projects Democrat Mark Warner will win re-election in Virginia over Bert Mizusawa, while Debbie Wasserman Schultz won the Florida 20th district House seat. CNN and AP project Jon Ossoff will be re-elected in Georgia over Mike Collins, but a runoff on December 1 would follow if no candidate wins a majority. Democrats also won Senate races in New Jersey, Illinois, Delaware, Massachusetts and Rhode Island. Early projections are not final results, and some close races may take hours or even days to decide.
- Democrats claim control of the US Senate
According to the AP, Democrats have won control of the Senate after Josh Turek won the Iowa race, bringing their total, including independents who caucus with them, to 51 seats. The shift could change the path of the stalled CLARITY Act, reshape committee leadership and bring closer scrutiny of Trump-linked crypto businesses and regulators' decisions. The CLARITY Act failed a Senate procedural vote 49 to 50 in September, and if it is not passed by January, the next Congress starts from scratch. Jerome de Tychey, president of Ethereum France, said nothing will pass without cross-partisan support and warned that the biggest risk for US crypto is becoming a partisan issue.
- Why Shake Shack Stock Jumped 20% in October
Shake Shack shares rose 20% in October according to S&P Global Market Intelligence, amid a broader rotation into restaurant stocks as investors sold AI stocks. The gain was supported by plans to enter Brazil through a licensing partnership, several positive analyst notes, including Morgan Stanley raising its price target from $74 to $79 and UBS lifting its target from $68 to $73, and a late-month jump tied to Nelson Peltz's buyout proposal for Wendy's. Shake Shack will report third-quarter earnings on Thursday, with analysts expecting revenue to grow 16% to $426.3 million and adjusted EPS to fall from $0.36 to $0.34. Investors will watch same-store sales growth and margins, as the company has struggled to turn revenue growth into profit growth.
- Financial markets turbulent, safe-haven assets gain favor, except gold
Volatility from the AI rally has pushed investors toward US Treasuries, the dollar, the Swiss franc and the yen, but gold has not attracted inflows. Gold fell below 4,000 USD/ounce, its lowest level in a year, while central bank gold purchases rose 42% in the third quarter to 321 tonnes. Since the US and Israel first attacked Iran, gold has lost about a quarter of its value and is down 9% year to date in USD terms, the weakest of 14 major asset classes in Bank of America's ranking. Standard Chartered finds the correlation between gold and the S&P 500 has risen to 0.48 on a three-month rolling basis and 0.69 over one month. The bank's analysts say that in the short term, the need to raise cash could lead investors to sell gold rather than buy more.
- Over 2.5 million tax codes stuck: Debt write-off is not enough, a streamlined dissolution path is needed
The Ministry of Finance says that as of 23 October 2026, over 2.5 million taxpayers had ceased operating without completing procedures to close their tax codes or no longer operated at their registered address, including about 643,000 in status 03 and nearly 1.88 million in status 06. The ministry proposes waiving business licence fees and late-payment interest and reducing penalties for late tax filings, but lawyer Nguyen Van Duoc argues the bigger bottleneck is reconstructing years of accounting records, which is nearly infeasible for firms dormant for 10-20 years. He proposes allowing retroactive dissolution dates tied to when the tax authority determines a firm is no longer operating, alongside a streamlined dissolution process. As an example, a firm inactive since 2007 faced more than VND 78.2 million in charges that could fall to VND 6.9 million under the draft. VTCA proposes classifying files and handling cases based on data.
- Asian FX gains as dollar falls on U.S. midterm results, yuan weakens on PBOC move
Most Asian currencies strengthened on Wednesday as the dollar retreated amid uncertainty over U.S. midterm results, while the yuan stayed weaker after Beijing moved to curb its recent rally. The Reserve Bank of Australia raised its cash rate by 25 basis points to 4.85%, its fifth increase this year and the highest level in 18 years, in a surprisingly divided 6-3 vote that fuelled expectations the tightening cycle may be nearing its end. The U.S. dollar index fell 0.5% to 101.34, the South Korean won gained 0.5% to 1,337.98 per dollar, and the yen strengthened 0.7% to 157.64 per dollar. Democrat Jon Ossoff won re-election in Georgia and Roy Cooper flipped a Republican-held Senate seat in North Carolina, while control of Congress remained uncertain, and the 10-year Treasury yield fell 4 basis points to 4.919%. Brent crude traded around $103.85 a barrel after falling about 1% to a near four-week low, as markets weighed diplomatic efforts to end the conflicts in Iran and Ukraine against the risk that further attacks disrupt supplies.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.